L‐aromatic amino acid decarboxylase < L‐dopa < L‐dopa challenge

Facettes :

List of bibliographic references indexed by L‐dopa

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000582 (2010)	Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]	Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets
000790 (2010)	Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis]	Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
000A11 (2009)	Giovanni Fabbrini [Italie] ; Giovanni Defazio [Italie] ; Carlo Colosimo [Italie] ; Antonio Suppa [Italie] ; Maria Bloise [Italie] ; Alfredo Berardelli [Italie]	Onset and spread of dyskinesias and motor symptoms in Parkinson's disease
000B02 (2009)	Tobias B Umer [Allemagne] ; Ute Hidding [Allemagne] ; Wolfgang Hamel [Allemagne] ; Carsten Buhmann [Allemagne] ; Christian K. E. Moll [Allemagne] ; Christian Gerloff [Allemagne] ; Michael Orth [Allemagne] ; Hartwig Roman Siebner [Allemagne] ; Alexander Münchau [Allemagne]	Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease
000C98 (2008)	Peter Jenner [Royaume-Uni]	Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities
000D31 (2008)	Maryka Quik [États-Unis] ; Kathryn O'Leary [États-Unis] ; Caroline M. Tanner [États-Unis]	Nicotine and Parkinson's disease: Implications for therapy
000D83 (2008)	Won Yong Lee [Corée du Sud] ; Won Tae Yoon [Corée du Sud] ; Hee Young Shin [Corée du Sud] ; Seong Hee Jeon [Corée du Sud] ; Poong-Lyul Rhee [Corée du Sud]	Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease
000E20 (2008)	Lars Timmermann [Allemagne] ; Martin Braun [Allemagne] ; Stefan Groiss [Allemagne] ; Lars Wojtecki [Allemagne] ; Stefan Ostrowski [Allemagne] ; Holger Krause [Allemagne] ; Bettina Pollok [Allemagne] ; Martin Südmeyer [Allemagne] ; Markus Ploner [Allemagne] ; Joachim Gross [Allemagne] ; Mohammad Maarouf [Allemagne] ; Jürgen Voges [Allemagne] ; Volker Sturm [Allemagne] ; Alfons Schnitzler [Allemagne]	Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease
001124 (2007)	Annalisa Pinna [Italie] ; Silvia Pontis [Italie] ; Franco Borsini [Italie] ; Micaela Morelli [Italie]	Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease
001317 (2006)	Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni]	Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study
001402 (2005)	Meg Morris [Australie] ; Robert Iansek [Australie] ; Jennifer Mcginley [Australie] ; Thomas Matyas [Australie] ; Frances Huxham [Australie]	Three‐dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder
001526 (2005)	Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]	Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech
001776 (2003)	Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]	Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study
001778 (2003)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
001916 (2002)	Diego Garcia-Borreguero [Espagne] ; Ana B. Caminero [Espagne] ; Yolanda De La Llave [Espagne] ; Oscar Larrosa [Espagne] ; Soledad Barrio [Espagne] ; Juan J. Granizo [Espagne] ; Juan A. Pareja [Espagne]	Decreased phasic EMG activity during rapid eye movement sleep in treatment‐naïve Parkinson's disease: Effects of treatment with levodopa and progression of illness
002B07 (1982)	M. Markianos [Grèce] ; M. Hadjikonstantinou [Grèce] ; E. Bistolaki [Grèce]	Urinary noradrenaline and serotonin metabolites in drug‐free Parkinson patients and the effect of L‐dopa treatment

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "L‐dopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "L‐dopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    L‐dopa
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024